• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tandem claims 1st remote software update for insulin pump

March 2, 2017 By Sarah Faulkner

Tandem claims 1st remote software update for insulin pumpTandem Diabetes Care (NSDQ:TNDM) said today that it released a software update using the company’s Tandem Device Updater tool for its t:slim insulin pumps purchased before April 2015. It marks the 1st time an insulin pump manufacturer has provided a software update that employs customers’ personal computers.

The Mac and PC-compatible tool remotely overhauls Tandem’s insulin pump software, according to the company, and will update older insulin pumps to include an expansion of the reverse correction functionality, the ability to enter a manual bolus into the suggested bolus window, and off-pump cartridge filling.

“The innovative, 1st-of-its-kind Tandem Device Updater represents an important advancement in the way functionality is delivered to insulin pump users, making it possible to provide new pump features to our customers independent of the typical pump insurance replacement cycle,” president & CEO Kim Blickenstaff said in prepared remarks. “We are working on exciting new software updates to offer our customers as they are approved by the FDA, such as integration with Dexcom’s G5 Mobile CGM system and automated insulin delivery algorithms, and today’s launch is the 1st step in this direction.”

After the t:slim insulin pump won FDA clearance, Tandem surveyed 300 customers and found that 2/3 of the customers who participated in the beta release thought the product was easy to use. More than 90% of patients indicated that they would likely download future software updates, according to Tandem.

The San Diego-based company touts its t:slim G4 insulin pump as the 1st continuous glucose monitoring-enabled pump with touchscreen capabilities.

In July last year, Tandem won FDA 510(k) clearance for an expanded pediatric indication for its t:slim insulin pump, now indicated for use in children 6 and older.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS